1. Home
  2. UNII Search
  3. UNII X573657P6P

UNII X573657P6P

HISTIDINE HYDROCHLORIDE MONOHYDRATE

Table of Contents

  1. UNII Information
  2. UNII Synonyms and Mappings
  3. UNII Resources
  4. UNII Crossover to NDC Codes

UNII Information

Unique Ingredient Identifier: X573657P6P
The Unique Ingredient Identifier (UNII) is a unique alphanumeric code assigned to a specific substance or ingredient by the FDA (Food and Drug Administration). UNII codes are non-proprietary, free, unique, unambiguous and nonsemantic. Each UNII code consists of 10 characters with both letters and numbers. The first two characters represent the source of the substance while the remaining eight characters represent the specific substance. UNII codes are primarily used to identify and track substances in several drug databases and regulatory documents related to drugs, biologics, and medical devices.
Formula: C6H9N3O2.ClH.H2O
Molecular Formula, total atoms represented as a molecular structure in a UNII description.
Preferred Substance Name: HISTIDINE HYDROCHLORIDE MONOHYDRATE
The Preferred Substance Name (PSN) is the official or preferred name of a substance or ingredient. The preferred name provides a standardized and consistent name for each substance is used in the UNII code system. The preferred name may differ from other names also commonly used to refer the same substance. The PSN is usually the name used by regulatory agencies like the FDA.
InChIKey: CMXXUDSWGMGYLZ-XRIGFGBMSA-N
The InChIKey to a unique identifier for a specific substance or ingredient that is based on its molecular structure. InChIKey stands for International Chemical Identifier Key and is a fixed-length string created from the IUPAC International Chemical Identifier (InChI). The InChIKey is useful in drug development and chemical analysis, where the molecular structure of a substance is an important factor in determining its properties and effects.
SMILES: n1c(C[C@@H](C(O)=O)N)c[nH]c1.Cl.O
The Simplified Molecular Input Line Entry System or SMILES is a format used to represent and describe the molecular structure of a substance or ingredient. SMILES uses a series of alphanumeric characters to represent the atoms and bonds in a molecule in conjunction with other symbols and operators to indicate the arrangement and connectivity of the atoms.
Registry Number: 5934-29-2
The Registry Number is the unique numerical identifiers assigned to a substance or ingredient by the Chemical Abstracts Service (CAS). The CAS registry number is a used and recognized standard identifier by many industries and regulatory agencies. The Registry Number facilitates cross-referencing substances between different databases that may use different naming conventions or identifiers.
NCI Thesaurus Concept Code: C87334
The NCI Thesaurus give reference terminology for many systems. The code includes vocabulary for clinical care, translational research, basic research, public information and administrative activities.
UNII to RxNorm Crosswalk: 1305609 (RXCUI)
The RxNorm Ingredient Concept Code is the numeric code assigned to a specific substance or ingredient by the National Library of Medicine's RxNorm system. By including the RxNorm code in the UNII code system it is possible to crossover UNII codes to RxNom.
PubChem Compound ID: 165377
The PubChem Compound ID is a unique identifier for a specific substance or ingredient in the PubChem database which is the largest collection of freely accessible chemical information by the National Center for Biotechnology Information. The PubChem database is a resource for drug discovery, development, chemical research, and other applications.
Ingredient Type: INGREDIENT SUBSTANCE
Substance Type: 01f3934d-de54-4d7c-923a-0a45b5f60ddf
The International Organization for Standardization - ISO 11238 substance type is used as a data element in the UNII code system to provide additional information about the type of substance being identified.

UNII Synonyms and Mappings

The following synonyms and mappings provide alternative ways to refer to the same substance or ingredient. Synonyms may include different names or spellings, alternate chemical names, trade names, or other common names.

  • HISTIDINE HYDROCHLORIDE MONOHYDRATE - Systematic Name (chemical and taxonomic names)
  • HISTIDINE HYDROCHLORIDE MONOHYDRATE [EP MONOGRAPH] - Common Name
  • HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE - Systematic Name (chemical and taxonomic names)
  • HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE, (-)- - Systematic Name (chemical and taxonomic names)
  • HISTIDINE, L-, HYDROCHLORIDE MONOHYDRATE - Systematic Name (chemical and taxonomic names)
  • HISTIDINE, L-, MONOHYDROCHLORIDE MONOHYDRATE - Common Name
  • L-HISTIDINE HYDROCHLORIDE HYDRATE [JAN] - Common Name
  • L-HISTIDINE MONOHYDROCHLORIDE [FCC] - Common Name
  • L-HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE - Systematic Name (chemical and taxonomic names)
  • L-HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE [USP-RS] - Common Name
  • L-HISTIDINE, HYDROCHLORIDE, HYDRATE (1:1:1) - Systematic Name (chemical and taxonomic names)

UNII Resources

Common Chemistry
CAS Common Chemistry is an open community resource of the American Chemical Society for accessing chemical information. The chemical information in the CAS database is curated by expert scientists and includes information of common and frequently regulated chemicals and information applicable to high school and undergraduate chemistry classes.
Inxight Drugs
The National Center for Advancing Translational Sciences (NCATS) Inxight Drugs database has a comprehensive drug development information. The NCATS Inxight Drugs includes manually curated data provided by private companies and FDA. The database has marketing and regulatory status information, rigorous drug ingredient definitions, biological activity, clinical use, etc.
DailyMed Regulated Products
The National Library of Medicine DailyMed is a searchable database that includes the most recent product labeling information submitted to the FDA by private companies.
NCATS GSRS Full Record
The Global Substance Registration System (GSRS) was designed to facilitate global monitoring of human and animal medicinal, food, tobacco, and cosmetic products. GSRS includes unique substance identifiers consistent with the ISO 11238 standard.
NCI Thesaurus
NCI Thesaurus (NCIt) by the National Cancer Institute provides reference terminology for clinical care, translational and basic research, and public information and administrative activities.
PubChem
The PubChem database by the National Library of Medicine includes the chemical structures of small organic molecules and information on their biological activities.

UNII Crossover to NDC Codes

This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory:

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0002-1436Proprietary Name: Emgality Galcanezumab-gnlmInjection, SolutionSubcutaneousEli Lilly And CompanyACTIVE
0002-1436Proprietary Name: Galcanezumab-gnlmInjection, SolutionEli Lilly And CompanyACTIVE
0002-2377Proprietary Name: Galcanezumab-gnlmInjection, SolutionEli Lilly And CompanyACTIVE
0002-2377Proprietary Name: Emgality Galcanezumab-gnlmInjection, SolutionSubcutaneousEli Lilly And CompanyACTIVE
0002-3115Proprietary Name: Emgality Galcanezumab-gnlmInjection, SolutionSubcutaneousEli Lilly And CompanyACTIVE
0002-3115Proprietary Name: Galcanezumab-gnlmInjection, SolutionEli Lilly And CompanyACTIVE
0002-7589Proprietary Name: Bebtelovimab Eli Lilly And Company
0002-7910Proprietary Name: Bamlanivimab Eli Lilly And Company
0002-7950Proprietary Name: Etesevimab Eli Lilly And Company
0003-6120Proprietary Name: Opdivo Qvantig Nivolumab And Hyaluronidase-nvhyInjection, SolutionSubcutaneousE.r. Squibb & Sons, L.l.c.ACTIVE
0003-7125Proprietary Name: Opdualag Nivolumab And Relatlimab-rmbwInjectionIntravenousE.r. Squibb & Sons, L.l.c.ACTIVE
0024-0654Proprietary Name: Sarclisa IsatuximabInjection, Solution, ConcentrateIntravenousSanofi-aventis U.s. LlcACTIVE
0024-0656Proprietary Name: Sarclisa IsatuximabInjection, Solution, ConcentrateIntravenousSanofi-aventis U.s. LlcACTIVE
0069-0238Proprietary Name: Ruxience Rituximab-pvvrInjection, SolutionIntravenousPfizer Laboratories Div Pfizer IncACTIVE
0069-0249Proprietary Name: Ruxience Rituximab-pvvrInjection, SolutionIntravenousPfizer Laboratories Div Pfizer IncACTIVE
0069-0305Proprietary Name: Trazimera Trastuzumab-qyypKitPfizer Laboratories Div Pfizer IncACTIVE
0069-2522Proprietary Name: Elrexfio Elranatamab-bcmmInjection, SolutionSubcutaneousPfizer Laboratories Div Pfizer IncACTIVE
0069-4494Proprietary Name: Elrexfio Elranatamab-bcmmInjection, SolutionSubcutaneousPfizer Laboratories Div Pfizer IncACTIVE
0078-0639Proprietary Name: Cosentyx SecukinumabInjectionSubcutaneousNovartis Pharmaceuticals CorporationACTIVE
0078-1056Proprietary Name: Cosentyx SecukinumabInjectionSubcutaneousNovartis Pharmaceuticals CorporationACTIVE
0310-3040Proprietary Name: Saphnelo Anifrolumab-fniaInjection, SolutionIntravenousAstrazeneca Pharmaceuticals LpACTIVE
0310-4500Proprietary Name: Imfinzi DurvalumabInjection, SolutionIntravenousAstrazeneca Pharmaceuticals LpACTIVE
0310-4505Proprietary Name: Imjudo TremelimumabInjection, SolutionIntravenousAstrazeneca Pharmaceuticals LpACTIVE
0310-4535Proprietary Name: Imjudo TremelimumabInjection, SolutionIntravenousAstrazeneca Pharmaceuticals LpACTIVE
0310-4611Proprietary Name: Imfinzi DurvalumabInjection, SolutionIntravenousAstrazeneca Pharmaceuticals LpACTIVE
49281-574Proprietary Name: Beyfortus NirsevimabInjectionIntramuscularSanofi Pasteur Inc.ACTIVE
49281-575Proprietary Name: Beyfortus NirsevimabInjectionIntramuscularSanofi Pasteur Inc.ACTIVE
50090-6704Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousA-s Medication SolutionsACTIVE
50090-6705Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousA-s Medication SolutionsACTIVE
50090-6706Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousA-s Medication SolutionsACTIVE
50090-6707Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousA-s Medication SolutionsACTIVE
50242-040Proprietary Name: Xolair OmalizumabInjection, SolutionSubcutaneousGenentech, Inc.ACTIVE
50242-070Proprietary Name: Gazyva ObinutuzumabInjection, Solution, ConcentrateIntravenousGenentech, Inc.ACTIVE
50242-077Proprietary Name: Herceptin Hylecta Trastuzumab And Hyaluronidase-oyskInjection, SolutionSubcutaneousGenentech, Inc.ACTIVE
50242-077Proprietary Name: Herceptin Hylecta Genentech, Inc.
50242-108Proprietary Name: Rituxan Hycela Rituximab And HyaluronidaseInjection, SolutionSubcutaneousGenentech, Inc.ACTIVE
50242-109Proprietary Name: Rituxan Hycela Rituximab And HyaluronidaseInjection, SolutionSubcutaneousGenentech, Inc.ACTIVE
50242-125Proprietary Name: Columvi GlofitamabSolution, ConcentrateIntravenousGenentech, Inc.ACTIVE
50242-127Proprietary Name: Columvi GlofitamabConcentrateIntravenousGenentech, Inc.ACTIVE
50242-132Proprietary Name: Herceptin TrastuzumabInjection, Powder, Lyophilized, For SolutionIntravenousGenentech, Inc.ACTIVE
50242-138Proprietary Name: Actemra TocilizumabInjection, SolutionSubcutaneousGenentech, Inc.ACTIVE
50242-214Proprietary Name: Xolair Pfs OmalizumabInjection, SolutionSubcutaneousGenentech, Inc.ACTIVE
50242-215Proprietary Name: Xolair Pfs OmalizumabInjection, SolutionSubcutaneousGenentech, Inc.ACTIVE
51144-003Proprietary Name: Tivdak Tisotumab VedotinInjection, Powder, For SolutionIntravenousSeagen Inc.ACTIVE
51144-020Proprietary Name: Padcev EJFVEnfortumab VedotinInjection, Powder, Lyophilized, For SolutionIntravenousSeagen Inc.ACTIVE
51144-030Proprietary Name: Padcev EJFVEnfortumab VedotinInjection, Powder, Lyophilized, For SolutionIntravenousSeagen Inc.ACTIVE
51759-505Proprietary Name: Selarsdi Ustekinumab-aeknInjection, SolutionSubcutaneousTeva Pharmaceuticals Usa, Inc.ACTIVE
51759-607Proprietary Name: Selarsdi Ustekinumab-aeknInjection, SolutionSubcutaneousTeva Pharmaceuticals Usa, Inc.ACTIVE
51759-708Proprietary Name: Selarsdi Ustekinumab-aeknInjection, SolutionIntravenousTeva Pharmaceuticals Usa, Inc.ACTIVE
55513-132Proprietary Name: Kanjinti Trastuzumab-annsInjection, Powder, Lyophilized, For SolutionIntravenousAmgen IncACTIVE
57894-054Proprietary Name: Stelara UstekinumabSolutionIntravenousJanssen Biotech, Inc.ACTIVE
57894-060Proprietary Name: Stelara UstekinumabInjection, SolutionSubcutaneousJanssen Biotech, Inc.ACTIVE
57894-061Proprietary Name: Stelara UstekinumabInjection, SolutionSubcutaneousJanssen Biotech, Inc.ACTIVE
57894-070Proprietary Name: Simponi GolimumabInjection, SolutionSubcutaneousJanssen Biotech, Inc.ACTIVE
57894-071Proprietary Name: Simponi GolimumabInjection, SolutionSubcutaneousJanssen Biotech, Inc.ACTIVE
57894-350Proprietary Name: Simponi Aria GolimumabSolutionIntravenousJanssen Biotech, Inc.ACTIVE
57894-501Proprietary Name: Rybrevant AmivantamabInjectionIntravenousJanssen Biotech, Inc.ACTIVE
57894-503Proprietary Name: Darzalex Faspro Daratumumab And Hyaluronidase-fihj (human Recombinant)InjectionSubcutaneousJanssen Biotech, Inc.ACTIVE
57894-640Proprietary Name: Tremfya GuselkumabInjectionSubcutaneousJanssen Biotech, Inc.ACTIVE
58468-0426Proprietary Name: Nexviazyme ngptAvalglucosidase AlfaInjection, Powder, Lyophilized, For SolutionIntravenousGenzyme CorporationACTIVE
61314-624Proprietary Name: Cimerli Ranibizumab-eqrnInjection, SolutionIntravitrealSandoz IncACTIVE
61314-625Proprietary Name: Cimerli Ranibizumab-eqrnInjection, SolutionIntravitrealSandoz IncACTIVE
61755-008Proprietary Name: Libtayo Cemiplimab-rwlcInjectionIntravenousRegeneron Pharmaceuticals, Inc.ACTIVE
61755-010Proprietary Name: Evkeeza EvinacumabInjection, Solution, ConcentrateIntravenousRegeneron Pharmaceuticals, Inc.ACTIVE
61755-013Proprietary Name: Evkeeza EvinacumabInjection, Solution, ConcentrateIntravenousRegeneron Pharmaceuticals, Inc.ACTIVE
61755-014Proprietary Name: Veopoz PozelimabInjection, SolutionIntravenous; SubcutaneousRegeneron Pharmaceuticals, Inc.ACTIVE
61755-018Proprietary Name: Inmazeb Atoltivimab, Maftivimab, And Odesivimab-ebgnInjection, SolutionIntravenousRegeneron Pharmaceuticals, Inc.ACTIVE
61755-024Proprietary Name: Casirivimab Regeneron Pharmaceuticals, Inc.
61755-025Proprietary Name: Imdevimab Regeneron Pharmaceuticals, Inc.
61755-026Proprietary Name: Casirivimab Regeneron Pharmaceuticals, Inc.
61755-027Proprietary Name: Imdevimab Regeneron Pharmaceuticals, Inc.
61755-050Proprietary Name: Eylea Hd AfliberceptInjection, SolutionIntravitrealRegeneron Pharmaceuticals, IncACTIVE
61755-051Proprietary Name: Eylea Hd AfliberceptInjection, SolutionIntravitrealRegeneron Pharmaceuticals, IncACTIVE
62856-212Proprietary Name: Leqembi LecanemabInjection, SolutionIntravenousEisai Inc.ACTIVE
62856-215Proprietary Name: Leqembi LecanemabInjection, SolutionIntravenousEisai Inc.ACTIVE
63539-252Proprietary Name: Elrexfio Elranatamab-bcmmInjection, SolutionSubcutaneousU.s. PharmaceuticalsACTIVE
64406-022Proprietary Name: Tofidence TocilizumabInjectionIntravenousBiogen Ma Inc.ACTIVE
64406-023Proprietary Name: Tofidence TocilizumabInjectionIntravenousBiogen Ma Inc.ACTIVE
64406-024Proprietary Name: Tofidence TocilizumabInjectionIntravenousBiogen Ma Inc.ACTIVE
64406-101Proprietary Name: Aduhelm Biogen Inc.
64406-102Proprietary Name: Aduhelm Biogen Inc.
65219-828Proprietary Name: Otulfi Ustekinumab-aauzSolutionIntravenousFresenius Kabi Usa, LlcACTIVE
65597-406Proprietary Name: Enhertu Fam-trastuzumab Deruxtecan-nxkiInjection, Powder, Lyophilized, For SolutionIntravenousDaiichi Sankyo Inc.ACTIVE
65597-801Proprietary Name: Datroway Datopotamab DeruxtecanInjection, Powder, Lyophilized, For SolutionIntravenousDaiichi Sankyo Inc.ACTIVE
66658-501Proprietary Name: Gamifant Emapalumab-lzsgInjectionIntravenousSwedish Orphan Biovitrum Ab (publ)ACTIVE
66658-505Proprietary Name: Gamifant Emapalumab-lzsgInjectionIntravenousSwedish Orphan Biovitrum Ab (publ)ACTIVE
67386-130Proprietary Name: Vyepti Eptinezumab-jjmrInjectionIntravenousLundbeck Pharmaceuticals LlcACTIVE
69448-015Proprietary Name: Hercessi Trastuzumab-strfInjection, Powder, Lyophilized, For SolutionIntravenousAccord Biopharma Inc.ACTIVE
69448-016Proprietary Name: Hercessi Trastuzumab-strfInjection, Powder, Lyophilized, For SolutionIntravenousAccord Biopharma Inc.ACTIVE
70114-210Proprietary Name: Yusimry Coherus Biosciences IncINACTIVATED
70114-220Proprietary Name: Yusimry Coherus Biosciences IncINACTIVATED
70114-440Proprietary Name: Cimerli Ranibizumab-eqrnInjection, SolutionIntravitrealCoherus Biosciences IncACTIVE
70114-441Proprietary Name: Cimerli Ranibizumab-eqrnInjection, SolutionIntravitrealCoherus Biosciences IncACTIVE
71288-815Proprietary Name: Yusimry Adalimumab-aqvhInjection, SolutionSubcutaneousMeitheal Pharmaceuticals Inc.ACTIVE
71288-816Proprietary Name: Yusimry Adalimumab-aqvhInjection, SolutionSubcutaneousMeitheal Pharmaceuticals Inc.ACTIVE
71837-1000Proprietary Name: Bizengri ZenocutuzumabInjectionIntravenousPartner Therapeutics, Inc.ACTIVE
72606-027Proprietary Name: Steqeyma Ustekinumab-stbaInjection, SolutionSubcutaneousCelltrion Usa Inc.ACTIVE
72606-028Proprietary Name: Steqeyma Ustekinumab-stbaInjection, SolutionSubcutaneousCelltrion Usa Inc.ACTIVE
72606-029Proprietary Name: Steqeyma Ustekinumab-stbaInjection, SolutionIntravenousCelltrion Usa Inc.ACTIVE
72677-551Proprietary Name: Uplizna InebilizumabInjectionIntravenousViela Bio, Inc.ACTIVE
73539-001Proprietary Name: Lantidra DonislecelSolutionIntravascularCelltrans Inc.ACTIVE
75987-130Proprietary Name: Tepezza TeprotumumabInjection, Powder, Lyophilized, For SolutionIntravenousHorizon Therapeutics Usa, Inc.ACTIVE
75987-150Proprietary Name: Uplizna InebilizumabInjectionIntravenousHorizon Therapeutics Usa, Inc.ACTIVE
78206-147Proprietary Name: Ontruzant TrastuzumabInjection, Powder, Lyophilized, For SolutionIntravenousOrganon LlcACTIVE
78206-148Proprietary Name: Ontruzant OntruzantKitIntravenousOrganon LlcACTIVE
78206-183Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousOrganon LlcACTIVE
78206-184Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousOrganon LlcACTIVE
78206-185Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousOrganon LlcACTIVE
78206-186Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousOrganon LlcACTIVE
78206-187Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousOrganon LlcACTIVE
81960-031Proprietary Name: Pemgarda PemivibartInjectionIntravenousInvivyd, IncACTIVE
83077-100Proprietary Name: Bizengri ZenocutuzumabInjectionIntravenousMerus Us, Inc.ACTIVE
83257-023Proprietary Name: Yesintek UstekinumabInjection, SolutionSubcutaneousBiocon Biologics Inc.ACTIVE
83257-024Proprietary Name: Yesintek UstekinumabInjection, SolutionSubcutaneousBiocon Biologics Inc.ACTIVE
83257-025Proprietary Name: Yesintek UstekinumabInjection, SolutionSubcutaneousBiocon Biologics Inc.ACTIVE
83257-026Proprietary Name: Yesintek UstekinumabSolutionIntravenousBiocon Biologics Inc.ACTIVE
84612-055Proprietary Name: Wezlana Ustekinumab-auubInjection, SolutionSubcutaneousOptum Health Solutions (ireland) LimitedACTIVE
84612-066Proprietary Name: Wezlana Ustekinumab-auubInjection, SolutionIntravenousOptum Health Solutions (ireland) LimitedACTIVE
84612-076Proprietary Name: Wezlana Ustekinumab-auubInjection, SolutionSubcutaneousOptum Health Solutions (ireland) LimitedACTIVE
84612-089Proprietary Name: Wezlana Ustekinumab-auubInjection, SolutionSubcutaneousOptum Health Solutions (ireland) LimitedACTIVE
84612-855Proprietary Name: Wezlana Ustekinumab-auubInjection, SolutionSubcutaneousOptum Health Solutions (ireland) LimitedACTIVE
84612-876Proprietary Name: Wezlana Ustekinumab-auubInjection, SolutionSubcutaneousOptum Health Solutions (ireland) LimitedACTIVE
84612-889Proprietary Name: Wezlana Ustekinumab-auubInjection, SolutionSubcutaneousOptum Health Solutions (ireland) LimitedACTIVE